Roslyn Prichard

Roslyn Prichard

Auto-generated profile, based on publicly available information

Roslyn Prichard

University of the Sunshine Coast

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 July 2024 in Nurse Education in Practice
Verified
Journal Article
Closed access
ASAnthony James Summers
Anthony James Summers
MHMay El Haddad
May El Haddad
RPRoslyn Prichard
Roslyn Prichard
KCKaren-Ann Clarke
Karen-Ann Clarke
JLJoanne Lee
Joanne Lee
Florin OprescuFlorin Oprescu
Florin Oprescu

1 September 2016 in Heart & Lung
Verified
Journal Article
Closed access
MAMartha Abshire
Martha Abshire
RPRoslyn Prichard
Roslyn Prichard
MCMia Cajita
Mia Cajita
MDMichelle Digiacomo
Michelle Digiacomo
CHCheryl Himmelfarb
Cheryl Himmelfarb

1 April 2015 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
KMKavitha Muthiah
Kavitha Muthiah
DRDesiree Robson
Desiree Robson
RPRoslyn Prichard
Roslyn Prichard
RWRobyn Walker
Robyn Walker
SGSunil Gupta
Sunil Gupta
CHChristopher S. Hayward
Christopher S. Hayward

1 November 2011 in ASAIO Journal
Verified
Journal Article
Closed access
CHChristopher S. Hayward
Christopher S. Hayward
RSRobert Salamonsen
Robert Salamonsen
AKAnne M. Keogh
Anne M. Keogh
JWJohn Woodard
John Woodard
PAPeter Ayre
Peter Ayre
PSPhillip Spratt
Phillip Spratt
Third-generation continuous-flow left ventricular assist devices (LVAD) provide reduced pulsatility flow. We examined the safe working range for LVAD pump speed and the effect on pump output and cardiac function in 13 stable outpatients with VentrAssist-LVAD (Ventracor Ltd, Australia). Pump speed was decreased from a baseline mean of 2,073 ± 86 revolutions per minute (RPM, with corresponding mean flow of 5.59 ± 1.18 L/min, mean ± standard deviation) to an average low-speed of 1,835 ± 55 RPM (corresponding flow 4.68 ± 0.99 L/min) and up to high-speed of 2,315 ± 66 RPM (corresponding flow 6.30 ± 1.29 L/min). There was a strong linear relationship between alteration in speed and flow rates (r2 = 0.89, p < 0.00001) but marked interpatient variation. Downward titration to preset minimum 1,800 RPM was achieved in 9/13 (69%) and upward titration to the preset maximum 2,400 RPM was achieved in 4/13 (31%). Upward titration was stopped due to ventricular suction or nonsustained ventricular tachycardia (VT) in 4/13 (31%). Ventricular suction or VT (in 4/13) tended to be more common in patients with poor right ventricular (RV) function (p = 0.07). In summary, pump flow is stable within a relatively small speed range and should not be altered without close monitoring due to variation in response between patients, particularly with concomitant RV impairment.

1 October 2014 in Heart, Lung and Circulation
Verified
Journal Article
Closed access
SGSunil Gupta
Sunil Gupta
KWKei Woldendorp
Kei Woldendorp
KMKavitha Muthiah
Kavitha Muthiah
DRDesiree Robson
Desiree Robson
RPRoslyn Prichard
Roslyn Prichard
CHChristopher S. Hayward
Christopher S. Hayward

18 July 2014 in The International Journal of Artificial Organs
Verified
Journal Article
Closed access
RPRoslyn A. Prichard
Roslyn A. Prichard
MJMarcus Juul
Marcus Juul
GGGary Gazibarich
Gary Gazibarich
PDPatricia M. Davidson
Patricia M. Davidson
CMCarmel Mason
Carmel Mason
CHChristopher S. Hayward
Christopher S. Hayward
Background: Six-minute walk distance (6MWD) and maximal oxygen uptake (VO2 max) are used as prognostic tools in patients with heart failure (HF). Whether these tests provide similar information in the LVAD population is not known. Methods: Eight patients supported with VentrAssist rotary blood pump LVADs, underwent three days of testing that included 6MWD and VO2 max at normal, high or low speeds, generating twenty-four paired results. Results: The mean 6MWD was 438 (+/- 90 SD) m and the mean VO2 was 14.12 (+/-1.87) ml/kg/min. There was a modest correlation between VO2(max) and 6MWD (r = 0.56 p = 0.004), which improved (r = 0.72 p = 0.002) when patients with higher resting Pro BNP levels and larger left ventricular end diastolic diameters (LVEDD) were excluded. Conclusions: 6MWD is correlated with VO2 (max) in LVAD supported patients, with higher correlations in patients with better underlying cardiac function.